Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients

Geriatrics and Gerontology International

Volumn 15, Issue , 2015, Pages 53-58

  Hatanaka, Hirokuni ^a   Hanyu, Haruo ^a   Fukasawa, Raita ^a   Hirao, Kentaro ^a   Shimizu, Soichiro ^a   Kanetaka, Hidekazu ^a   Iwamoto, Toshihiko ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Alzheimer's disease; Anti oxidants; Mixed dementia; Oxidative stress; Vascular dementia

Indexed keywords

ALBUMIN; BILIRUBIN; BIOLOGICAL MARKER; HYDROPEROXIDE; REACTIVE OXYGEN METABOLITE; URIC ACID;

AGED; ALBUMIN BLOOD LEVEL; ALZHEIMER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN VENTRICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MIXED DEMENTIA; MULTIINFARCT DEMENTIA; OUTPATIENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; SCORING SYSTEM; URIC ACID BLOOD LEVEL; VERY ELDERLY; WHITE MATTER; AGING; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; GERIATRIC ASSESSMENT; JAPAN; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BIOMARKERS; CASE-CONTROL STUDIES; DEMENTIA; DEMENTIA, VASCULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; JAPAN; MALE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84949793135     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12659     Document Type: Article

References (25)

1. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75-80.
2. Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci 2007; 257: 80-87.
3. Zekry D, Hauw J-J, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002; 50: 1431-1438.
4. Bennett S, Grant MM, Sldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimer Dis 2009; 17: 245-257.
5. Polidori MC, Mattioli P, Aldred S etal. Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 18: 265-270.
6. Ihara Y, Hayabara T, Sasaki K etal. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J Neurol Sci 1997; 153: 76-81.
7. Casado A, Lopez-Fernandez ME, Casado MC, de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008; 33: 450-458.
8. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SRJ. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatry 1998; 13: 840-845.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
10. Roman GC, Tatemichi TK, Erkinjuntti T etal. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
11. Erkinjuntti T, Inzitari D, Pantoni L etal. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 2000; 59: 23-30.
12. American Psychiatric Association. Diagnostic and Statistical and Manual Disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.
13. Hanyu H, Kume K, Sato T etal. Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients. J Neurol Sci 2012; 323: 71-76.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Tanito M, Kaidzu S, Takai Y, Ohira A. Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLoS ONE 2012; 7: e49680.
16. Imatoh T, Kamimura S, Tanihara S. Moderate oxidative and high antioxidative activity are associated with steatosis in Japanese males. Clin Trans Sci 2013; 6: 45-49.
17. Hatanaka H, Hanyu H, Hirose D, Fukasawa R, Namioka N, Iwamoto T. Peripheral oxidative stress markers in Alzheimer disease patients with or without cerebrovascular disease. J Am Geriatr Soc 2015; 63: 1472-1474.
18. Schrag M, Mueller C, Zabel M etal. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 2013; 59: 100-110.
19. Kim TS, Pae CU, Yoon SY etal. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21: 344-348.
20. Gackowski D, Rozalski R, Siomek A etal. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. J Neurol Sci 2008; 266: 57-62.
21. Cankurtaran M, Yesil Y, Kuyumcu E etal. Altered levels of homocystein and serum natural antioxidants links oxidative damage to Alzheimer's disease. J Alzheimer Dis 2013; 33: 1051-1058.
22. Calkin AC, Giunti S, Sheehy KJ etal. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia 2008; 51: 1731-1740.
23. Melo JB, Sousa C, Garcao P, Oliveria CR, Agostinho P. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Eur J Neurosci 2009; 29: 455-464.
24. Farrall AJ, Wardlaw JW. Blood-brain barrier: ageing and microvascular disease - systemic review and meta-analysis. Neurobiol Aging 2009; 30: 337-352.
25. Skoumalova A, Hort J. Blood markers of oxidative stress in Alzheimer's disease. J Cell Mol Med 2012; 16: 2291-2300.